Merdury Biopharmaceutical Corporation (TPEX:6932)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
6.27
-0.22 (-3.39%)
Jun 18, 2026, 2:54 PM CST
Market Cap2.65B -50.6%
Revenue (ttm)n/a
Net Income-67.23M
EPS-0.16
Shares Out 422.03M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume278,464
Open6.49
Previous Close6.49
Day's Range6.27 - 6.59
52-Week Range4.95 - 12.50
Beta-1.29
Analystsn/a
Price Targetn/a
Earnings DateAug 10, 2026

About Merdury Biopharmaceutical

Merdury Biopharmaceutical Corporation engages in the development of drugs for unmet needs in Taiwan. The company develops StackDose platform, a drug development technology platform that integrates drug formulation, 3D powder printing, and hardware and software technologies to create drug-specific 3D printing production equipment, which can be used as a foundation for pharmaceutical companies to provide hosted services and in-house product development. It also offers formulation design and 3D pharmaceutical processing services. Merdury Biopharma... [Read more]

Sector Healthcare
Founded 2019
Employees 16
Stock Exchange Taipei Exchange
Ticker Symbol 6932
Full Company Profile

Financial Performance

Financial Statements